• Goldman Sachs
• 06 Mar, 2020

Today, more than 90% of new drugs fail clinical trials in the US, and those that do succeed can take upwards of seven years to reach FDA approval. Yet clinical trials, unlike other areas of healthcare, remain relatively untouched by digital innovations that could improve their success and efficiency.
Read more...